Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab. Klotz L, Meuth SG, Wiendl H Clin Immunol. 2012 Jan; 142(1):25-30. Epub 2011 Apr 15. PMID: 21550857. Abstract CommentRecommendBookmarkWatch